Can GDF-15 Predict Bleeding Risk in VTE? – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Timothy Hoberstorfer et al., adding:
“Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Growth differentiation factor-15 has been proposed as a marker of bleeding risk, but it did not deliver here.
In patients anticoagulated for acute venous thromboembolism, GDF-15 levels showed no association with clinically relevant bleeding and added nothing to existing bleeding prediction.
The result argues against using this biomarker to guide anticoagulation decisions in VTE.”
Title: Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
Authors: Timothy Hoberstorfer, Stephan Nopp, Daniel Steiner, Cornelia Englisch, Philip Kienzl, Benedikt Weber, Monika Fritzer-Szekeres, Ingrid Pabinger, Cihan Ay
Other articles about Journal of Thrombosis and Haemostasis on Hemostasis Today.
-
Sep 20, 2026, 09:51Ceasovschih Alexandr: A Closer Look at Lipid Disorders in CKM Syndrome
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC